Literature DB >> 31099830

Riboflavin Concentrations at the Endothelium During Corneal Cross-Linking in Humans.

Theo G Seiler1,2,3, Ana Batista4,5, Beatrice E Frueh1, Karsten Koenig4,5.   

Abstract

Purpose: To determine the riboflavin concentration in the posterior corneal stroma, Descemet's membrane, and endothelium prior to UV irradiation in corneal cross-linking (CXL) in humans.
Methods: Five human deepithelialized cadaver corneas were mounted into artificial anterior chambers. After the establishment of stable physiological hydration, two-photon imaging with a certified multiphoton tomograph was used to determine fluorescence intensity and second harmonic generation signals from collagen throughout each cornea by optical sectioning, with a step size of 2.5 μm. Afterward, 0.1% riboflavin solution was applied to the anterior corneal surface, similar to the standard CXL protocol. To determine the absolute riboflavin concentration immediately before UV irradiation, corneas were measured by two-photon imaging just at the end of the riboflavin imbibition and after riboflavin saturation.
Results: The topical application of 0.1% riboflavin results in a riboflavin concentration that decreases to 0.035% in the posterior stroma. Inside Descemet's membrane and endothelium, the concentration drops further to only approximately 0.015% at the endothelial level. Local riboflavin distribution indicates a predominantly paracellular passive diffusion of riboflavin into the anterior chamber.
Conclusion: The experimentally determined riboflavin concentration of 0.015% at the endothelium shows a substantial discrepancy of a factor of 1.7 to the previously theoretically calculated 0.025%. A lower riboflavin concentration at the endothelium may enable higher radiant exposures and further improve the efficacy of CXL.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31099830     DOI: 10.1167/iovs.19-26686

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  5 in total

Review 1.  [Treatment indications for corneal crosslinking and clinical results of new corneal crosslinking techniques].

Authors:  Klara Borgardts; Johannes Menzel-Severing; Gerd Geerling; Theo G Seiler
Journal:  Ophthalmologe       Date:  2022-02-11       Impact factor: 1.059

2.  Delayed-Onset Transient Light Sensitivity Syndrome after Corneal Collagen Cross-Linking: A Case Series.

Authors:  Majid Moshirfar; Uma Vaidyanathan; Grant C Hopping; Yasmyne C Ronquillo; Phillip C Hoopes
Journal:  Med Hypothesis Discov Innov Ophthalmol       Date:  2019

3.  Decreased Riboflavin Impregnation Time Does Not Increase the Risk for Endothelial Phototoxicity During Corneal Cross-Linking.

Authors:  Arie L Marcovich; Jurriaan Brekelmans; Alexander Brandis; Ilan Samish; Iddo Pinkas; Dina Preise; Keren Sasson; Ilan Feine; Alexandra Goz; Mor M Dickman; Rudy M M A Nuijts; Avigdor Scherz
Journal:  Transl Vis Sci Technol       Date:  2020-05-11       Impact factor: 3.283

4.  PACK-CXL vs. antimicrobial therapy for bacterial, fungal, and mixed infectious keratitis: a prospective randomized phase 3 trial.

Authors:  Farhad Hafezi; Mohammed Hosny; Rohit Shetty; Boris Knyazer; Shihao Chen; Qinmei Wang; Hassan Hashemi; Emilio A Torres-Netto
Journal:  Eye Vis (Lond)       Date:  2022-01-07

5.  Crosslinking-Induced Corneal Endothelium Dysfunction and Its Protection by Topical Ripasudil Treatment.

Authors:  Xuemei Wang; Yanlin Zhong; Minghui Liang; Zhirong Lin; Huping Wu; Cheng Li
Journal:  Dis Markers       Date:  2022-01-13       Impact factor: 3.434

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.